Ossium Health is a bioengineering company focused on improving human health, vitality, and longevity through innovative cell therapy solutions. The company pioneers a new paradigm in cell therapy by utilizing the deceased donor transplant ecosystem to combat diseases of the blood and immune systems. With a robust platform and pipeline targeting hematologic diseases, organ transplant rejection, and orthopedics, Ossium Health collaborates with healthcare providers, life science companies, and organ procurement organizations. Based in San Francisco and Indianapolis, Ossium Health aims to revolutionize bioengineering and cell therapy development for a healthier future.